Document is current
Any future updates will be listed below
-
Authors
Massart, Nicolas https://orcid.org/0000-0001-5828-0197
Camus, Christophe
Nesseler, Nicolas
Fillâtre, Pierre
Flecher, Erwan
Mansour, Alexandre
Verhoye, Jean-Philippe
Le Fevre, Lucie
Luyt, Charles-Edouard
- License Information
-
More Information
Article History
Received: 16 November 2022
Accepted: 18 March 2023
First Online: 7 April 2023
Declarations
:
: Patients or closest relative were informed of the anonymous prospective collection of their data for constitution of a cohort and had the possibility not to participate in the study. In case of refusal, the data were not collected accordingly. The study protocol received approval from the ethical committee of the French Intensive Care Society (CE 21-14).
: Patients or closest relative were informed of the anonymous prospective collection of the data and had the possibility not to participate in the study. In case of refusal, the data were not collected accordingly.
: CEL received lecture fees from Merck and AdvanzPharma outside the scope of the present work. The other authors have no competing interests to declare.
